RecruitingNot ApplicableNCT05693701

Multicomponent Intervention Study- Blood Donors With High Cholesterol

Implementing a Multicomponent Intervention to Treat Blood Donors With Familial Hypercholesterolemia

Sponsor

University of Texas Southwestern Medical Center

Enrollment

100 participants

Start Date

Feb 27, 2023

Study Type

INTERVENTIONAL

Conditions

Lipid Metabolism Disorder

Summary

The purpose and objective of this study is to improve cholesterol treatment among blood donors with FH (Familial Hypercholesterolemia).

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Implementation Strategy Bundle and Usual care notification for people with lipid metabolism disorder. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALImplementation Strategy Bundle

Bundle includes multimodal communications to notify donors about high cholesterol and its treatment, website with resources, and an optional care navigator. Resources for their primary care provider will also be disseminated.

OTHERUsual care notification

Carter BloodCare will notify participants of their high cholesterol, potential for genetic causes, and recommendation to see their care provider by sending its routine, standard notification letter. These participants will also be eligible to receive the intervention bundle at the end of the study.

Locations(1)

UT Southwestern Medical Center

Dallas, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05693701